¼¼°èÀÇ ÀüüÆ÷µµ¸·¿° ½ÃÀå º¸°í¼­(2025³â)
Panuveitis Global Market Report 2025
»óǰÄÚµå : 1720853
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 175 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,183,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 8,938,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,692,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

ÀüüÆ÷µµ¸·¿° ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¼ö³â°£ ±Þ¼ºÀåÀÌ Àü¸ÁµÉ ¿¹Á¤ÀÔ´Ï´Ù. ÅõÀÚ Áõ°¡, Áúȯ¿¡ ´ëÇÑ ÀǽÄÀÇ °íÁ¶¿¡ ±âÀÎÇÑ´Ù°í »ý°¢µË´Ï´Ù. ÀÌ ±â°£¿¡ ¿¹»óµÇ´Â ÁÖ¿ä µ¿Çâ¿¡´Â »ý¹°ÇÐÀû ¿ä¹ýÀÇ Ã¤¿ë È®´ë, ¼­¹æÇü µå·¯±× µô¸®¹ö¸® ½Ã½ºÅÛÀÇ °³¹ß, ¸ÂÃãÇü ÀÇ·á ¾îÇÁ·ÎÄ¡ÀÇ È®´ë, AI¸¦ Ȱ¿ëÇÑ Áø´Ü ¹× Ä¡·áÀÇ Áøº¸, Àúħ½À ¼ö¼ú ±â¼úÀÇ ´ëµÎ µîÀÌ ÀÖ½À´Ï´Ù.

ÀÚ°¡¸é¿ª ÁúȯÀÇ À¯º´·ü Áõ°¡´Â ÇâÈÄ ¸î ³â°£ÀÇ ÀüüÆ÷µµ¸·¿° ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯º´·üÀÇ »ó½ÂÀº À¯ÀüÀû ¼ÒÀÎ, ¿À¿°À̳ª ½Ä»ýȰÀÇ º¯È­ µîÀÇ È¯°æÀû ¿µÇâ, ¸é¿ª°è Á¶Àý ºÎÀüÀÇ Æ®¸®°Å°¡ µÇ´Â °¨¿°ÁõÀ̳ª ½ºÆ®·¹½º ¿äÀο¡ ´ëÇÑ Ãß°¡ ³ëÃâ µîÀÇ ¿äÀο¡ ±âÀÎÇϰí ÀÖ½À´Ï´Ù. ÀÚ°¡¸é¿ª ÁúȯÀº ÀÚ°¡¸é¿ª Ȱµ¿°ú °ü·ÃµÈ ¸¹Àº »ç·Êµé·Î ÀÎÇØ ¸é¿ª ü°è Á¶Àý¿¡ ´ëÇÑ ¿¬±¸¸¦ ÃËÁøÇÔÀ¸·Î½á ÆÇ´ººê¿° Ä¡·á¸¦ ¹ßÀü½Ã۰í ÀÖ½À´Ï´Ù. 2023³â 5¿ù¿¡ ¿µ±¹¿¡ º»»ç¸¦ µÐ ¿¬±¸ ±â°üÀÎ ¿Á½ºÆÛµå ´ëÇб³´Â ÀÚ°¡¸é¿ª ÁúȯÀÌ ¼¼°è Àα¸ÀÇ 10%¿¡ ¿µÇâÀ» ¹ÌÄ¡°í, ¿©¼ºÀÇ 13%, ³²¼ºÀÇ 7%°¡ ¿µÇâÀ» ¹Þ°í ÀÖ´Ù°í º¸°íÇß½À´Ï´Ù.

ÀüüÆ÷µµ¸·¿° ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº ȯÀÚÀÇ ÄÄÇöóÀÌ¾ð½º¿Í Ä¡·á È¿°ú¸¦ ³ôÀ̱â À§ÇØ Ã·´Ü ¼­¹æÇü À¯¸® ü³» ÁÖ»ç Á¦Á¦ÀÇ °³¹ßÀ» ¿ì¼±Çϰí ÀÖ½À´Ï´Ù. ü¾× Áß¿¡ Åõ¿©ÇÏ´Â ¾à¹°Àü´Þ ½Ã½ºÅÛÀ¸·Î, ºó¹øÇÑ Åõ¿©ÀÇ Çʿ伺À» ÃÖ¼ÒÈ­Çϸ鼭 Ä¡·á È¿°ú¸¦ Áö¼Ó½Ã۰í ÀÖ½À´Ï´Ù. Pharma´Â ¸Á¸·Áúȯ Ä¡·á¸¦ À§ÇÑ ÀáÀçÀûÀÎ ¸é¿ªÁ¶ÀýÁ¦ÀÎ TRS02ÀÇ °³¹ßÀ» ¹ßÇ¥Çß½À´Ï´Ù. Áúº´¿¡ ´ëóÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - °Å½Ã°æÁ¦ ½Ã³ª¸®¿À ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ½ÅÇü Äڷγª ¹ÙÀÌ·¯½º °¨¿°ÀÇ ¿µÇâ°ú ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°/±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ ÇÁ·ÎÆÄÀÏ

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀåÀÇ ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, Àü·«

Á¦36Àå ºÎ·Ï

SHW
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Panuveitis is an inflammatory condition that affects all three layers of the uvea include the iris, ciliary body, and choroid within the eye. If left untreated, it can cause pain, blurred vision, and potentially lead to vision loss. The primary goal of treatment is to control inflammation, alleviate symptoms, and prevent further eye damage that could impair vision. Timely intervention is crucial for maintaining eye health and preserving sight.

The main types of panuveitis include infectious and non-infectious panuveitis. Infectious panuveitis is caused by infectious agents and requires prompt diagnosis and treatment to prevent severe eye complications and vision impairment. Treatment options include pharmacological therapy, surgical interventions, and phototherapy, administered via oral, intravitreal, and topical routes. These treatments are distributed through hospital pharmacies, retail pharmacies, and online pharmacies, ensuring accessibility for patients.

The panuveitis market research report is one of a series of new reports from The Business Research Company that provides panuveitis market statistics, including the panuveitis industry global market size, regional shares, competitors with the panuveitis market share, detailed panuveitis market segments, market trends, and opportunities, and any further data you may need to thrive in the panuveitis industry. This panuveitis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The panuveitis market size has grown rapidly in recent years. It will grow from $4.05 billion in 2024 to $4.47 billion in 2025 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to the prevalence of autoimmune and infectious diseases, the increasing use of corticosteroids, the rising adoption of biologics, the growing demand for ophthalmic imaging, and expanding research investment in infectious causes.

The panuveitis market size is expected to see rapid growth in the next few years. It will grow to $6.58 billion in 2029 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to the expanding use of biologic therapies, increasing demand for personalized medicine, the rising prevalence of uveitis-linked diseases, higher investments in ophthalmic research, and growing disease awareness. Major trends expected during this period include the increasing adoption of biologic therapies, the development of sustained-release drug delivery systems, the expansion of personalized medicine approaches, advancements in AI-driven diagnosis and treatment, and the rise of minimally invasive surgical techniques.

The increasing prevalence of autoimmune disorders is expected to drive the growth of the panuveitis market in the coming years. Autoimmune diseases occur when the immune system mistakenly attacks the body's healthy cells and tissues. This rising prevalence is attributed to factors such as genetic predisposition, environmental influences such as pollution and dietary changes, and greater exposure to infections and stressors that can trigger immune system dysregulation. Autoimmune disorders are advancing panuveitis treatment by promoting research into immune system modulation, as many cases of panuveitis are linked to autoimmune activity. For instance, in May 2023, the University of Oxford, a UK-based research institution, reported that autoimmune disorders affect 10% of the global population, with 13% of women and 7% of men impacted. As a result, the increasing occurrence of autoimmune disorders is fueling the expansion of the panuveitis market.

Leading companies in the panuveitis market are prioritizing the development of advanced slow-release intravitreal injection formulations to enhance patient compliance and treatment effectiveness. A slow-release intravitreal injection formulation is a drug delivery system that gradually administers medication into the eye's vitreous humor over an extended period, ensuring sustained therapeutic effects while minimizing the need for frequent dosing. For example, in August 2022, Tarsier Pharma, an Israel-based clinical-stage company, announced the development of TRS02, a potential immunomodulator for the treatment of retinal diseases. This innovative therapy is designed to address various back-of-the-eye conditions with inflammatory pathologies, including posterior uveitis (panuveitis) and diabetic macular edema. TRS02, developed using Tarsier's proprietary technology platform, is advancing toward investigational new drug (IND) submission following successful preclinical milestones.

In July 2023, Harrow Health Inc., a US-based pharmaceutical company, acquired Santen Pharmaceutical Co., Ltd. for an undisclosed sum. This acquisition enables Harrow to expand its portfolio by integrating Santen's expertise in developing innovative treatments for uveitis and panuveitis. Santen Pharmaceutical Co. Ltd., a Japan-based company, specializes in treatments for panuveitis.

Major players in the panuveitis market are Pfizer Inc., AbbVie, Boehringer Ingelheim International GmbH, Amgen, Teva Pharmaceuticals, Sandoz, Organon group of companies, Zydus Lifesciences Ltd., Mallinckrodt plc, Alvotech, EyePoint Pharmaceuticals Inc., Affibody Medical AB, Alumis Inc., Fujifilm Kyowa Kirin Biologics Co. Ltd., Revolo Biotherapeutics Ltd., Tarsier Pharma, Priovant Therapeutics Inc., Mylan N.V., Clearside Biomedical Inc., pSivida Corp.

North America was the largest region in the panuveitis market in 2024. The regions covered in panuveitis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the panuveitis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The panuveitis market consists of revenues earned by entities providing services such as pharmaceutical treatment, surgical interventions, diagnostic services, and supportive care. The market value includes the value of related goods sold by the service providers or included within the service offering. The panuveitis market also includes sales of diagnostic tools, pharmaceuticals, biologic agents, immunosuppressive drugs, and supportive care products. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Panuveitis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on panuveitis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for panuveitis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The panuveitis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Panuveitis Market Characteristics

3. Panuveitis Market Trends And Strategies

4. Panuveitis Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Panuveitis Growth Analysis And Strategic Analysis Framework

6. Panuveitis Market Segmentation

7. Panuveitis Market Regional And Country Analysis

8. Asia-Pacific Panuveitis Market

9. China Panuveitis Market

10. India Panuveitis Market

11. Japan Panuveitis Market

12. Australia Panuveitis Market

13. Indonesia Panuveitis Market

14. South Korea Panuveitis Market

15. Western Europe Panuveitis Market

16. UK Panuveitis Market

17. Germany Panuveitis Market

18. France Panuveitis Market

19. Italy Panuveitis Market

20. Spain Panuveitis Market

21. Eastern Europe Panuveitis Market

22. Russia Panuveitis Market

23. North America Panuveitis Market

24. USA Panuveitis Market

25. Canada Panuveitis Market

26. South America Panuveitis Market

27. Brazil Panuveitis Market

28. Middle East Panuveitis Market

29. Africa Panuveitis Market

30. Panuveitis Market Competitive Landscape And Company Profiles

31. Panuveitis Market Other Major And Innovative Companies

32. Global Panuveitis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Panuveitis Market

34. Recent Developments In The Panuveitis Market

35. Panuveitis Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â